Revvity, Inc. (RVTY) stock
RVTYNYSELaboratory Analytical InstrumentsFiscal year ends December 29
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jul 5, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3042% above fair value
$147.79−1.06 (-0.71%)
Close on Nov 17, 2026Market cap $16.49BP/E 70.4Yield 0.19%
Revvity EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Revvity's EPS for the twelve months ending Jul 5, 2026 was $2.10, down 11.0% year over year. For fiscal 2025 it was $2.07, down 5.9% from the year before. Over ten years it grew 1.0% a year on average. The highest annual figure on record is $8.08 in fiscal 2021.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $2.07 | -5.9% |
| FY2024 | Dec 29, 2024 | $2.20 | -60.4% |
| FY2023 | Dec 31, 2023 | $5.55 | +23.3% |
| FY2022 | Jan 1, 2023 | $4.50 | -44.3% |
| FY2021 | Jan 2, 2022 | $8.08 | +24.5% |
| FY2020 | Jan 3, 2021 | $6.49 | +218.1% |
| FY2019 | Dec 29, 2019 | $2.04 | -4.2% |
| FY2018 | Dec 30, 2018 | $2.13 | -19.3% |
| FY2017 | Dec 31, 2017 | $2.64 | +24.5% |
| FY2016 | Jan 1, 2017 | $2.12 | +13.4% |
| FY2015 | Jan 3, 2016 | $1.87 | +34.5% |
| FY2014 | Dec 28, 2014 | $1.39 | -5.4% |
| FY2013 | Dec 29, 2013 | $1.47 | +141.0% |
| FY2012 | Dec 30, 2012 | $0.61 | +771.4% |
| FY2011 | Jan 1, 2012 | $0.07 | -97.9% |
| FY2010 | Jan 2, 2011 | $3.31 | +372.9% |
| FY2009 | Jan 3, 2010 | $0.70 | -34.6% |
| FY2008 | Dec 28, 2008 | $1.07 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jul 5, 2026 | $0.47 | +2.2% |
| Q1 FY2026 | Apr 5, 2026 | $0.36 | +2.9% |
| Q4 FY2025 | Dec 28, 2025 | $0.87 | +11.5% |
| Q3 FY2025 | Sep 28, 2025 | $0.40 | -48.1% |
| Q2 FY2025 | Jun 29, 2025 | $0.46 | +2.2% |
| Q1 FY2025 | Mar 30, 2025 | $0.35 | +66.7% |
| Q4 FY2024 | Dec 29, 2024 | $0.78 | +21.9% |
| Q3 FY2024 | Sep 29, 2024 | $0.77 | +862.5% |
| Q2 FY2024 | Jun 30, 2024 | $0.45 | +60.7% |
| Q1 FY2024 | Mar 31, 2024 | $0.21 | -95.3% |
| Q4 FY2023 | Dec 31, 2023 | $0.64 | -36.6% |
| Q3 FY2023 | Oct 1, 2023 | $0.08 | -88.1% |
| Q2 FY2023 | Jul 2, 2023 | $0.28 | -80.3% |
| Q1 FY2023 | Apr 2, 2023 | $4.50 | +221.4% |
| Q4 FY2022 | Jan 1, 2023 | $1.01 | -32.7% |
| Q3 FY2022 | Oct 2, 2022 | $0.67 | -39.6% |
| Q2 FY2022 | Jul 3, 2022 | $1.42 | -35.2% |
| Q1 FY2022 | Apr 3, 2022 | $1.40 | -58.5% |
| Q4 FY2021 | Jan 2, 2022 | $1.50 | -55.6% |
| Q3 FY2021 | Oct 3, 2021 | $1.11 | -29.3% |
| Q2 FY2021 | Jul 4, 2021 | $2.19 | +78.0% |
| Q1 FY2021 | Apr 4, 2021 | $3.37 | +1023.3% |
| Q4 FY2020 | Jan 3, 2021 | $3.38 | +482.8% |
| Q3 FY2020 | Oct 4, 2020 | $1.57 | +201.9% |
| Q2 FY2020 | Jul 5, 2020 | $1.23 | +98.4% |
| Q1 FY2020 | Apr 5, 2020 | $0.30 | -6.3% |
| Q4 FY2019 | Dec 29, 2019 | $0.58 | -9.4% |
| Q3 FY2019 | Sep 29, 2019 | $0.52 | -24.6% |
| Q2 FY2019 | Jun 30, 2019 | $0.62 | +8.8% |
| Q1 FY2019 | Mar 31, 2019 | $0.32 | +39.1% |
| Q4 FY2018 | Dec 30, 2018 | $0.64 | – |
| Q3 FY2018 | Sep 30, 2018 | $0.69 | -15.9% |
| Q2 FY2018 | Jul 1, 2018 | $0.57 | -69.0% |
| Q1 FY2018 | Apr 1, 2018 | $0.23 | -34.3% |
| Q4 FY2017 | Dec 31, 2017 | -$0.37 | -162.7% |
| Q3 FY2017 | Oct 1, 2017 | $0.82 | +54.7% |
| Q2 FY2017 | Jul 2, 2017 | $1.84 | – |
| Q1 FY2017 | Apr 2, 2017 | $0.35 | – |
| Q4 FY2016 | Jan 1, 2017 | $0.59 | – |
| Q3 FY2016 | Oct 2, 2016 | $0.53 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?